258 related articles for article (PubMed ID: 16596186)
1. Expression of CD137 and CD137 ligand in colorectal cancer patients.
Dimberg J; Hugander A; Wågsäter D
Oncol Rep; 2006 May; 15(5):1197-200. PubMed ID: 16596186
[TBL] [Abstract][Full Text] [Related]
2. Increased soluble 4-1BB ligand (4-1BBL) levels in peripheral blood of patients with multiple sclerosis.
Liu GZ; Gomes AC; Putheti P; Karrenbauer V; Kostulas K; Press R; Hillert J; Hjelmström P; Gao XG
Scand J Immunol; 2006 Oct; 64(4):412-9. PubMed ID: 16970683
[TBL] [Abstract][Full Text] [Related]
3. Rapid induction of CD95 ligand and CD4+ T cell-mediated apoptosis by CD137 (4-1BB) costimulation.
Ebata T; Mogi S; Hata Y; Fujimoto JI; Yagita H; Okumura K; Azuma M
Eur J Immunol; 2001 May; 31(5):1410-6. PubMed ID: 11465097
[TBL] [Abstract][Full Text] [Related]
4. CD137 and CD137 ligand constitutively coexpressed on human T and B leukemia cells signal proliferation and survival.
Palma C; Binaschi M; Bigioni M; Maggi CA; Goso C
Int J Cancer; 2004 Jan; 108(3):390-8. PubMed ID: 14648705
[TBL] [Abstract][Full Text] [Related]
5. Loss of KAI1 expression in the progression of colorectal cancer.
Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
[TBL] [Abstract][Full Text] [Related]
6. Functional expression of 4-1BB (CD137) in the inflammatory tissue in Crohn's disease.
Maerten P; Geboes K; De Hertogh G; Shen C; Cadot P; Bullens DM; Van Assche G; Penninckx F; Rutgeerts P; Ceuppens JL
Clin Immunol; 2004 Sep; 112(3):239-46. PubMed ID: 15308117
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD137 and its ligand in human neurons, astrocytes, and microglia: modulation by FGF-2.
Reali C; Curto M; Sogos V; Scintu F; Pauly S; Schwarz H; Gremo F
J Neurosci Res; 2003 Oct; 74(1):67-73. PubMed ID: 13130507
[TBL] [Abstract][Full Text] [Related]
8. CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling.
Langstein J; Michel J; Fritsche J; Kreutz M; Andreesen R; Schwarz H
J Immunol; 1998 Mar; 160(5):2488-94. PubMed ID: 9498794
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD137 monoclonal antibody promotes the direct anti-tumor effect mediated by peripheral blood-derived human dendritic cells in vitro.
Zhang L; Wang Q; Wang X; Ding P; Song J; Ma C; Sun W
Cell Mol Immunol; 2004 Feb; 1(1):71-6. PubMed ID: 16212924
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of CD137 and LPS effects on monocyte activation, survival, and proliferation.
Langstein J; Becke FM; Söllner L; Krause G; Brockhoff G; Kreutz M; Andreesen R; Schwarz H
Biochem Biophys Res Commun; 2000 Jun; 273(1):117-22. PubMed ID: 10873573
[TBL] [Abstract][Full Text] [Related]
11. Role of 4-1BB:4-1BB ligand in cancer immunotherapy.
Cheuk AT; Mufti GJ; Guinn BA
Cancer Gene Ther; 2004 Mar; 11(3):215-26. PubMed ID: 14671675
[TBL] [Abstract][Full Text] [Related]
12. Protein expression of the chemokine, CCL28, in human colorectal cancer.
Dimberg J; Hugander A; Wågsäter D
Int J Oncol; 2006 Feb; 28(2):315-9. PubMed ID: 16391784
[TBL] [Abstract][Full Text] [Related]
13. CD137 is expressed by follicular dendritic cells and costimulates B lymphocyte activation in germinal centers.
Pauly S; Broll K; Wittmann M; Giegerich G; Schwarz H
J Leukoc Biol; 2002 Jul; 72(1):35-42. PubMed ID: 12101260
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of the chemokine CCL21 in human colorectal adenocarcinomas.
Mumtaz M; Wågsäter D; Löfgren S; Hugander A; Zar N; Dimberg J
Oncol Rep; 2009 Jan; 21(1):153-8. PubMed ID: 19082456
[TBL] [Abstract][Full Text] [Related]
15. CD137 ligand signalling induces differentiation of primary acute myeloid leukaemia cells.
Cheng K; Wong SC; Linn YC; Ho LP; Chng WJ; Schwarz H
Br J Haematol; 2014 Apr; 165(1):134-44. PubMed ID: 24428589
[TBL] [Abstract][Full Text] [Related]
16. Role of the CD137 ligand (CD137L) signaling pathway during Mycobacterium tuberculosis infection.
Martínez Gómez JM; Koh VH; Yan B; Lin W; Ang ML; Rahim SZ; Pethe K; Schwarz H; Alonso S
Immunobiology; 2014 Jan; 219(1):78-86. PubMed ID: 24091276
[TBL] [Abstract][Full Text] [Related]
17. Targeted and untargeted CD137L fusion proteins for the immunotherapy of experimental solid tumors.
Zhang N; Sadun RE; Arias RS; Flanagan ML; Sachsman SM; Nien YC; Khawli LA; Hu P; Epstein AL
Clin Cancer Res; 2007 May; 13(9):2758-67. PubMed ID: 17460060
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in relation to cadherin expression in patients with colorectal carcinoma.
Tsujitani S; Saito H; Honboh T; Ataka M; Tanida T; Makino M; Ikeguchi M
Dis Colon Rectum; 2007 Aug; 50(8):1241-9. PubMed ID: 17429708
[TBL] [Abstract][Full Text] [Related]
19. Assessment expression of the adhesion molecules, CD134 and CD137, in patients with colorectal cancer by flow cytometry.
Cepowicz D; Stasiak-Barmuta A; Zalewski B; Piotrowski Z
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():34-6. PubMed ID: 15638367
[TBL] [Abstract][Full Text] [Related]
20. CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice.
Olofsson PS; Söderström LA; Wågsäter D; Sheikine Y; Ocaya P; Lang F; Rabu C; Chen L; Rudling M; Aukrust P; Hedin U; Paulsson-Berne G; Sirsjö A; Hansson GK
Circulation; 2008 Mar; 117(10):1292-301. PubMed ID: 18285570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
